Showing results (271-280 of 290) with videos related to
Sort By:
Pageof 29
Molecular Biology of the Cell|June 1, 2007
Activated ezrin promotes cell migration through recruitment of the GEF Dbl to lipid rafts and preferential downstream activation of Cdc42Soren Prag, Maddy Parsons, Melanie D Keppler, et al.Molecular and Cellular Biology|March 25, 2009
Integrating receptor signal inputs that influence small Rho GTPase activation dynamics at the immunological synapseKonstantina Makrogianneli, Leo M Carlin, Melanie D Keppler, et al.Journal of Immunological Methods|December 6, 2005
Filter Buffy Coats (FBC): a source of peripheral blood leukocytes recovered from leukocyte depletion filtersT P H Meyer, I Zehnter, B Hofmann, et al.Cureus|December 7, 2019
PREMISE: Posterior Circulation Results Comparing Embolectomy to Medical Intervention in Stroke EmergenciesPatrick M Chen, Mohsen Pirastehfar, Lovella Hailey, et al.Proteins|March 30, 2004
A hierarchical approach to all-atom protein loop predictionMatthew P Jacobson, David L Pincus, Chaya S Rapp, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 10, 2013
Does symptom onset to primary stroke center time goals affect stroke outcome?Bryant Chee, Rema Raman, Karin Ernstrom, et al.Gastroenterology|June 2, 2000
Enhanced urinary excretion of cysteinyl leukotrienes in patients with acute alcohol intoxicationM Uemura, W D Lehmann, W Schneider, et al.Leukemia|August 5, 2005
Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia GroupsS Amadori, S Suciu, R Stasi, et al.Molecular and Cellular Biology|July 26, 2002
Site-directed perturbation of protein kinase C- integrin interaction blocks carcinoma cell chemotaxisMaddy Parsons, Melanie D Keppler, Adam Kline, et al.European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final resultsM Sinn, T Liersch, H Riess, et al.Pageof 29